CHRISTOPHER TANNER: Open Payments
NPI 1922566728 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ABBVIE INC. | 1 | $33 |
| Lundbeck LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, REXULTI, Kerendia, The Cologuard Plus Collection Kit, XIFAXAN, Rybelsus, QULIPTA, LEQVIO.
Industry payments across MI — which companies pay providers there.
